(New York) -- (February 23, 2006) -- Colon cancer patients considering participation in a clinical trial can now access a first-of-its-kind peer-to-peer support system, the Buddy Program, the Colon Cancer Alliance (CCA) announced today. As a result of this innovation, an experienced mentor will provide guidance to newly diagnosed patients about how to prepare for clinical trials and understand the process. The announcement comes as the CCA marks the seventh Annual National Colorectal Cancer Awareness Month in March.
Although more Americans have become aware of colon cancer in recent years, one person still dies of the disease every nine minutes. Research shows the mortality rate will likely decrease if patients and caregivers have a better understanding of how to treat the disease. In fact, thousands of clinical trials are available for patients to try new, experimental and investigational drugs. But fewer than five percent of adult cancer patients currently choose to participate in them.
"For the first time, colorectal cancer patients will have the opportunity to be educated about clinical trials by someone who has just been in their shoes," said Amy Kelly, Co-Founder and Executive Director of the CCA. "We expect that the intimacy of this experience will encourage more patients to join trials. As more people participate, we will develop the necessary research to find the best treatments for the disease."
Since 1995, participation in clinical trials has declined due to long-standing fear, apprehension and skepticism. Doctors also may not mention trials as an option and access problems still exist. To help maximize the CCA's Buddy Program and address some of these problems, all potential mentors will undergo training to ensure that they can offer the most appropriate guidance. The clinical trial component will expand an existing program in which colon cancer survivors, their families and friends are able to speak to others who have "been t
'"/>
24-Feb-2006
Page: 1 2 Related medicine news :1.
Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer2.
Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative3.
Clinical review -- A psychological approach to the management of irritable bowel syndrome4.
NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 20075.
Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference6.
Clinical guidelines for blood conservation during cardiac procedures developed7.
Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 20078.
Clinical trial coordinators need more financial conflict-of-interest training9.
Clinical studies evaluate potential treatments for mouth ulcers10.
NIH names Clinical Trial Units for the Microbicide Trials Network11.
Clinical Trials Units selected for newly restructured HIV/AIDS research networks